Healthcare -
Biotechnology - NASDAQ - US
$ 6.46
-1.37 %
$ 177 M
Market Cap
-161.5
P/E
FENC - STOCK-BASED COMPENSATION
Stock-based Compensation FENC - Fennec Pharmaceuticals Inc.
5.35 M
LAST VALUE
15.48%
2 YEAR CAGR
24.02%
5 YEAR CAGR
50.98%
10 YEAR CAGR